Renalase is removed by kidneys and during dialysis - excess related to CKD complications?

Jolanta Malyszko1, Ewa Koc-Zorawska, Marcin Zorawski

  • 12nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University, 15-276 Bialystok, M. Sklodowskiej-Curie 24a, Poland. jolmal@poczta.onet.pl.

Insights

Kidney disease (CKD) complications like hypertension may involve renalase. This study found renalase in ultrafiltrate and urine, with levels varying by kidney function and dialysis type, suggesting a role in CKD cardiovascular risks.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Chronic kidney disease (CKD) commonly leads to hypertension and cardiovascular (CV) disorders.
  • Renalase, produced by kidneys and cardiomyocytes, is implicated in CKD-related hypertension and CV complications.
  • Conflicting data exists regarding serum renalase levels in CKD patients, necessitating further investigation.

Purpose of the Study:

  • To assess serum renalase concentration in CKD patients undergoing different dialysis modalities (hemodialysis [HD] and hemodiafiltration [HDF]) and nephrectomy statuses.
  • To investigate the presence and levels of renalase in urine and ultrafiltrate of hemodialysis patients.
  • To evaluate the impact of hemodialysis sessions on renalase concentrations.

Main Methods:

  • Assessed renalase concentration in plasma, ultrafiltrate, and urine of 100 hemodialysis patients using commercial tests.
  • Included 17 hemodiafiltration patients and 24 healthy controls in the study.
  • Utilized Western Blot analysis to further assess renalase concentration.

Main Results:

  • Renalase was detected in the ultrafiltrate of hemodialysis patients, irrespective of dialyzer type.
  • Urine renalase concentration was higher in healthy controls than in hemodialysis patients.
  • Anuric patients exhibited higher renalase concentrations than those with residual diuresis; renalase correlated with urine output and was lower in HDF than HD patients.

Conclusions:

  • The kidneys eliminate renalase, and its elevated levels may contribute to cardiovascular diseases in CKD patients.
  • Findings suggest renalase plays a role in the pathophysiology of CKD and its associated cardiovascular complications.
  • Further research is warranted to elucidate the precise mechanisms linking renalase to cardiovascular risk in CKD.
Abstract

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.1K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.3K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.0K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
383
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
503
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
662